Pacira | Passivo Circulante



Current Liabilities Alterar Data
Astellas Pharma JPY 1.15T 59.2B 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
J&J USD 50.32B 1.44B 2024-12
Ligand Pharmaceuticals USD 37.11M 12.34M 2024-12
Novo Nordisk 208.36B 20.45B 2024-09
Pacira USD 309.92M 3.52M 2024-12
Perrigo USD 1.04B 406.3M 2024-12
Pfizer USD 43B 216M 2024-12
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Teva Pharmaceutical Industries USD 12.8B 1B 2024-12
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12
Zoetis USD 3.41B 1.71B 2024-12



Pacira Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.